05/07/2024 6:40 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 6:43 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 3:46 PM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
04/29/2024 3:48 PM | Intra-Cellular Therapies (Filer)
| Form ARS | |
04/24/2024 3:20 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2024 4:23 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/18/2024 4:25 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
04/16/2024 3:40 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:37 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/16/2024 6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 3:15 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:15 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 4:15 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 7:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 7:31 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:31 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:32 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:33 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:33 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:52 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:38 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:45 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:30 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:30 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 4:58 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:58 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:58 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:44 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 3:36 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 3:27 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:04 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:41 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:57 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:59 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Jeff Bezos & 48 Members of Congress Are Buying ONE Sector… (Ad) Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy?
And why are they all piling into ONE unique corner of the market… Click here for the details |
02/27/2024 7:00 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 7:00 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:22 PM | Intra-Cellular Therapies (Subject) VAN NOSTRAND ROBERT L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:46 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:46 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:33 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:22 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:42 AM | Intra-Cellular Therapies (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/09/2024 11:40 AM | Intra-Cellular Therapies (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024 5:02 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:07 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:10 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:13 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:47 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:39 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:41 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 6:47 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 4:08 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 5:02 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:45 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 6:54 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 5:43 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 5:46 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:38 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 10:15 AM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:52 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 4:31 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 3:15 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023 12:06 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 7:01 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 7:01 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2023 4:29 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 4:30 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 7:40 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 3:13 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023 3:13 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:18 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 3:40 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023 5:05 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 5:09 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023 6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 6:44 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/20/2023 4:47 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2023 3:13 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/07/2023 5:07 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4/A | |
07/07/2023 5:07 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4/A | |
07/07/2023 5:08 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4/A | |
07/05/2023 3:30 PM | Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The Scary Fed Idea To Turn Your Dollars Into a Digital Power Grab (Ad) Cash is becoming a relic of the past…
Soon, Biden and the Federal Reserve plan to replace the dollar with their own controllable, traceable, programmable digital currency. Act now and claim your free information kit before it's too late! |
07/05/2023 3:30 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:11 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:11 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:12 PM | Intra-Cellular Therapies (Issuer) Salas Eduardo Rene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:12 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |